Literature DB >> 19822955

Variations in serum transforming growth factor-beta1 levels with gender, age and lifestyle factors of healthy Japanese adults.

Yingsong Lin1, Kei Nakachi, Yoshinori Ito, Shogo Kikuchi, Akiko Tamakoshi, Kiyoko Yagyu, Yoshiyuki Watanabe, Yutaka Inaba.   

Abstract

Elevated serum or plasma Transforming Growth Factor-beta1 (TGF-beta1) {levels have been} linked to cancer and other diseases in numerous studies; however, very few studies have reported an association between circulating TGF-beta1 and lifestyle factors in healthy people. We examined the association between serum TGF-beta1 levels and gender, age, body mass index (BMI), smoking, and drinking in a large population-based cohort study (N =9,142). Serum TGF-beta1 levels were {detected by the Quantikine enzyme-linked immunoassay kit (R&D Systems). The data indicated highly significant (p< ;0.0001) difference in serum TGF-beta1 levels between men (mean value: 37.6 +/- 0.12 ng/mL, N=4888) and women (mean value: 35.1 +/- 0.12 ng/ml, N=4254)}. Serum TGF-beta1 levels decreased with age (trend p< 0.0001) and were positively associated with obesity (trend p< 0.0001) in both men and women. We observed a significant trend with increased serum TGF-beta1 levels corresponding to increased amount of tobacco and alcohol consumption in men (trend p< 0.0001). These findings suggest that serum TGF-beta1 levels appear to be modulated by {gender}, age and lifestyle factors such as obesity, cigarette smoking, and alcohol drinking in healthy Japanese adults.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19822955      PMCID: PMC3834674          DOI: 10.3233/DMA-2009-0643

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  23 in total

1.  Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling.

Authors:  Hariom Yadav; Celia Quijano; Anil K Kamaraju; Oksana Gavrilova; Rana Malek; Weiping Chen; Patricia Zerfas; Duan Zhigang; Elizabeth C Wright; Christina Stuelten; Peter Sun; Scott Lonning; Monica Skarulis; Anne E Sumner; Toren Finkel; Sushil G Rane
Journal:  Cell Metab       Date:  2011-07-06       Impact factor: 27.287

2.  Antipsychotics activate the TGFβ pathway effector SMAD3.

Authors:  T Cohen; S Sundaresh; F Levine
Journal:  Mol Psychiatry       Date:  2012-01-31       Impact factor: 15.992

3.  Host age is a systemic regulator of gene expression impacting cancer progression.

Authors:  Afshin Beheshti; Sébastien Benzekry; J Tyson McDonald; Lili Ma; Michael Peluso; Philip Hahnfeldt; Lynn Hlatky
Journal:  Cancer Res       Date:  2015-03-02       Impact factor: 12.701

4.  The regulatory protein SnoN antagonizes activin/Smad2 protein signaling and thereby promotes adipocyte differentiation and obesity in mice.

Authors:  Qingwei Zhu; Amanda Chang; Albert Xu; Kunxin Luo
Journal:  J Biol Chem       Date:  2018-07-20       Impact factor: 5.157

5.  Associations of the Transforming Growth Factor β/Smad Pathway, Body Mass Index, and Physical Activity With Breast Cancer Outcomes: Results From the Shanghai Breast Cancer Study.

Authors:  Yinghao Su; Hui Cai; Ying Zheng; Qingchao Qiu; Wei Lu; Xiao Ou Shu; Qiuyin Cai
Journal:  Am J Epidemiol       Date:  2016-09-19       Impact factor: 4.897

Review 6.  Sugar, sex, and TGF-β in diabetic nephropathy.

Authors:  Maggie K Diamond-Stanic; Young H You; Kumar Sharma
Journal:  Semin Nephrol       Date:  2012-05       Impact factor: 5.299

7.  Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studies.

Authors:  Eric J Jacobs; Christina C Newton; Debra T Silverman; Leticia M Nogueira; Demetrius Albanes; Satu Männistö; Michael Pollak; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Causes Control       Date:  2014-06-10       Impact factor: 2.506

8.  Age- and gender-associated changes in the concentrations of serum TGF-1β, DHEA-S and IGF-1 in healthy captive baboons (Papio hamadryas anubis).

Authors:  E L Willis; R F Wolf; G L White; D McFarlane
Journal:  Gen Comp Endocrinol       Date:  2013-10-23       Impact factor: 2.822

9.  The additional value of TGFβ1 and IL-7 to predict the course of prostate cancer progression.

Authors:  Caroline Schroten; Natasja F Dits; Ewout W Steyerberg; Ries Kranse; Arno G J L H van Leenders; Chris H Bangma; Robert Kraaij
Journal:  Cancer Immunol Immunother       Date:  2011-11-24       Impact factor: 6.968

Review 10.  Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors.

Authors:  Annalisa Giandalia; Alfio Edoardo Giuffrida; Guido Gembillo; Domenico Cucinotta; Giovanni Squadrito; Domenico Santoro; Giuseppina T Russo
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.